Compositions and methods for combating lower urinary tract dysfunctions with delta opioid receptor agonists

Details for Australian Patent Application No. 2003228991 (hide)

Owner Mount Cook Biosciences, Inc.

Inventors Pendergast, William; Biciunas, Kestutis P.; Gengo, J. Peter; Ma, Xin; Jan, ShyiTai; Chang, Kwen-Jen

Agent Callinan

Pub. Number AU-B-2003228991

PCT Number PCT/US03/14730

PCT Pub. Number WO2003/094853

Priority 60/379,186 09.05.02 US; 10/434,004 08.05.03 US

Filing date 9 May 2003

Wipo publication date 11 November 2003

Acceptance publication date 6 December 2007

International Classifications

C07D 241/04 (2006.01) Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings

A61K 31/4465 (2006.01) - only substituted in position 4

A61K 31/495 (2006.01) - having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine

A61K 31/496 (2006.01) - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 13/02 (2006.01) Drugs for disorders of the urinary system

A61P 13/08 (2006.01) Drugs for disorders of the urinary system

A61P 13/10 (2006.01) Drugs for disorders of the urinary system

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07D 211/70 (2006.01) Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

C07D 401/06 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 417/06 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

14 August 2003 Complete Application Filed

  Priority application(s): 60/379,186 09.05.02 US; 10/434,004 08.05.03 US

15 January 2004 Application Open to Public Inspection

  Published as AU-B-2003228991

26 July 2007 Assignment before Grant

  Ardent Pharmaceuticals, Inc. The application has been assigned to Mount Cook Biosciences, Inc.

6 December 2007 Application Accepted

  Published as AU-B-2003228991

3 April 2008 Standard Patent Sealed

2 July 2009 Corrigenda

  Applications Accepted - Name Index Under the name Mount Cook Biosciences, Inc., Application No. 2003228991, under INID (43) correct the Publication Date to read 24 November 2003.

3 December 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003228992-METHOD AND APPARATUS FOR ACCOMMODATING HIGH BANDWIDTH DATA TRAFFIC ON A WIRELESS NETWORK

2003228990-HYDROXYPHOSPHONATES AND PHOSPHONOPHOSPHATES AS APOLIPOPROTEIN E MODULATORS